MJA
MJA

Inappropriate prescribing for osteoporosis

B E Christopher Nordin, Michael Horowitz and Barry E Chatterton
Med J Aust 2009; 190 (9): . || doi: 10.5694/j.1326-5377.2009.tb02544.x
Published online: 4 May 2009

To the Editor: We believe the current indications for subsidised treatment of osteoporosis specified in the Pharmaceutical Benefits Schedule (PBS) encourage over-prescribing on the one hand, yet, on the other, deny many patients with osteoporosis the treatment they need.

Online responses are no longer available. Please refer to our instructions for authors page for more information.